Company intelligence / Profile preview

Guangzhou Darui Biotechnology

Guangzhou, Guangdong, China

Ownership: Private
Employees: ~500
Development stage: Other

Overview

Guangzhou Darui Biotechnology is a leading Chinese diagnostics company with commercially available in vitro diagnostic platforms for oncology, inherited diseases, prenatal screening, and infectious disease. It is recognized for high-throughput genetic testing (NGS, MassARRAY), immunoassay, and molecular diagnostics, with major regulatory certifications (CFDA, CE, ISO13485) and extensive clinical use across China.[1][3][4][5][7][11]

Therapeutic areas: Women's HealthOncologyInfectious DiseasesRare Diseases
Modalities: Diagnostic testDeviceNext generation sequencingMass spectrometry-based assayImmunoassay
Industry: Molecular Diagnostics

Partnerships

Agena Bioscience

Beyond the preview

Go deeper on Guangzhou Darui Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Guangzhou Darui Biotechnology.

Explore the full profile